EKSO - Ekso Bionics Holdings, Inc. Stock Analysis | Stock Taper
Logo

About Ekso Bionics Holdings, Inc.

https://www.eksobionics.com

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.

Scott G. Davis

CEO

Scott G. Davis

Compensation Summary
(Year 2024)

Salary $375,000
Bonus $94,501
All Other Compensation $3,516
Total Compensation $473,017
Industry Medical - Instruments & Supplies
Sector Healthcare
Went public January 17, 2014
Method of going public IPO
Full time employees 61

Split Record

Date Type Ratio
2025-06-02 Reverse 1:15
2025-05-27 Reverse 1:15

ETFs Holding This Stock

Summary

Total 2

Showing Top 2 of 2

Ratings Snapshot

Rating : C+

Discounted Cash Flow 4
Return On Equity 1
Return On Assets 1
Debt To Equity 2
Price To Earnings 1
Price To Book 4
Overall Score 2

Most Recent Analyst Grades

Grade Summary

Buy 1
Neutral 1

Showing Top 2 of 2

Price Target

Target High $6
Target Low $6
Target Median $6
Target Consensus $6

Institutional Ownership